Posts in category Ups/Downs


Analysts Punish Otonomy Inc (OTIC) in Wake of Meniere’s Disease Drug Failure

Wednesday turned out to be a nightmare for Otonomy Inc (NASDAQ:OTIC) investors, after the drug …

Read more

Party Pooper: Standpoint Research Downgrades DSW Inc. Shares

Standpoint Research Moves to Sidelines as DSW Delivers Upbeat Earnings

Read more

Healthcare Sell-Side Analysts Head to Sidelines on CoLucid Pharmaceuticals Inc (CLCD) and Alcobra Ltd (ADHD)

CoLucid Pharmaceuticals Inc CoLucid Pharmaceuticals Inc (NASDAQ:CLCD) shares are on the run today after the …

Read more

Here’s Why Cempra Inc (CEMP) Shares Are Falling 9% Today

Cempra Inc (NASDAQ:CEMP) seen its shares falling nearly 9% (as of this writing), after analyst Ritu …

Read more

Here’s Why Needham Downgraded Cempra Inc (CEMP) Shares Today

In a research report released Friday, Needham analyst Alan Carr downgraded shares of Cempra Inc …

Read more

Notable Analyst Downgrades in Healthcare: Concordia International Corp (CXRX), Teva Pharmaceutical (TEVA)

Concordia International Corp Concordia International Corp (NASDAQ:CXRX) shares collapsed today, falling nearly 40%, after the Canadian …

Read more

Here’s Why JPMorgan Turned Bearish on Ariad Pharmaceuticals, Inc. (ARIA)

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) shares tumbled nearly 7% today, after J.P. Morgan analyst Anupam Rama turned bearish …

Read more

This Top Analyst Downgrades Twitter Inc (TWTR); Sees Less Attractive Risk/Reward

Twitter Inc (NYSE:TWTR) shares jumped nearly 25% following the rumors that Salesforce.com and Google have expressed interest …

Read more

William Blair Upgrades and Bumps Up Price Target on Sarepta Therapeutics Inc (SRPT) Following FDA Accelerated Approval

On Monday, September 19th, the FDA granted accelerated approval to Sarepta Therapeutics Inc (NASDAQ:SRPT) pipeline …

Read more

Bull of the Day: Sarepta Therapeutics Inc (SRPT)

After a long regulatory process filled with delays and intense speculation, the FDA finally approved …

Read more